Brigham and Women's Hospital Harvard Medical School
home research news contact us patients lab members

Clemens R. Scherzer, M.D.

Assistant Professor of Neurology
Harvard Medical School

Co-Director
Harvard NeuroDiscovery Biomarker Program

Associate Neurologist
Brigham and Women's Hospital
Massachusetts General Hospital

Email: cscherzer@partners.org

To cure Parkinson’s disease new drugs and diagnostics are needed. We look at a global view of gene activity in human Parkinson’s disease to discover disease genes, drug targets, and molecular biomarkers. We integrate large scale clinical studies with genome-wide expression analysis and genetic validation in Parkinson’s and other neurodegenerative diseases.

Transcriptional regulation of α-synuclein: insights from blood?
Future Neurology, March 2009

Interview - Searching for biomarkers in Parkinson's disease
Biomarkers in Medicine, April, 2009

Heme Gene Controller May Be a New Path To Treatment of Parkinson Disease
Neurology Today, September 4, 2008 »more

Genetic mechanisms linked to Parkinson’s disease uncovered
Harvard University Gazette, July 24, 2008 »more

A PD Trifecta: Synuclein Gene Expression, Aging, and Inflammation
Alzheimer Research Form »more

News Archived